export default function ThymosinA1OverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        Thymosin Alpha-1 is a peptide your thymus naturally produces to coordinate how your immune system matures and responds. It doesn&rsquo;t stimulate the immune system like a vaccine adjuvant — it helps calibrate it, nudging it toward a more competent, balanced state. It has human clinical trial data in specific immune conditions and is approved in about 35 countries, though not in the US.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Average Person &mdash; Immune Resilience After Illness</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I keep getting sick every few months, or I&rsquo;ve never fully bounced back from a bad illness. Someone mentioned thymosin alpha-1 can help your immune system function better. Is this real?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>It&rsquo;s described as &ldquo;modulating&rdquo; rather than &ldquo;stimulating&rdquo; the immune system</strong><br />For people who are tired of getting sick but nervous about compounds that blast their immune response into overdrive, the modulation framing is appealing. Thymosin Alpha-1 helps T cells mature and dendritic cells activate — it supports the infrastructure of a competent immune response rather than hitting an alarm button.</li>
          <li><strong>It has actual human clinical data in immune contexts</strong><br />Unlike most community immune peptides that exist only in animal studies, Thymosin Alpha-1 (brand name Zadaxin) has been studied in humans for hepatitis B, hepatitis C, and in some cancer immunotherapy support contexts. That clinical experience exists, even if none of it was in &ldquo;generally healthy people who get sick a lot.&rdquo;</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The human trial evidence is in specific disease populations — viral hepatitis and cancer — not in people who just want stronger immune resilience. Whether the same immune calibration effect translates to healthy adults experiencing normal immune cycling is extrapolated from the mechanism, not proven. It&rsquo;s also not appropriate for anyone with an autoimmune condition, where activating the immune system further can make things significantly worse. Net: thoughtfully framed and more clinically credentialed than most immune peptides, but the wellness use case is still extrapolated, not directly studied.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; Staying Healthy Through Heavy Training</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;Heavy training blocks suppress my immune system and I always get sick at the worst times. Can thymosin alpha-1 help me stay healthy during high-volume periods?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The &ldquo;open window&rdquo; of immune suppression after hard training is a documented phenomenon</strong><br />Intense endurance or strength training temporarily depresses immune function — the so-called &ldquo;open window&rdquo; where infection risk rises. An immune modulator that supports T cell competence during this window is conceptually well-matched to the problem athletes actually experience.</li>
          <li><strong>Post-illness recovery periods matter for training continuity</strong><br />Even if the primary goal isn&rsquo;t immune optimization per se, shortening post-illness recovery and improving immune resilience has real performance implications for anyone who loses two weeks of training to an upper respiratory infection every few months.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">No clinical trials have studied thymosin alpha-1 specifically in athletes during heavy training. The mechanism is plausible for the use case, but &ldquo;mechanistically plausible&rdquo; is not the same as &ldquo;demonstrated to work in your situation.&rdquo; The compound is not appropriate during active infection — it&rsquo;s an immune calibrator, not an acute treatment. And anyone with any autoimmune condition should not use it without specialist involvement. Net: reasonable harm-benefit framing for immune-resilient athletes with no autoimmune concerns, but the evidence is not sport-specific.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; Immune Architecture and Longevity</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;The thymus involutes with age and immune competence declines. Thymosin Alpha-1 is endogenous thymic output. Is this the most mechanistically grounded immune longevity intervention available?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Thymic involution is one of the most documented features of immune aging</strong><br />The thymus shrinks dramatically after puberty, producing less thymosin and other immune-maturation signals. By middle age, thymic tissue is largely replaced by fat. The hypothesis that supplementing with a thymic peptide could partially restore immune competence is mechanistically coherent and directly addresses a documented age-related decline.</li>
          <li><strong>T cell maturation and dendritic cell activation are upstream of many other immune functions</strong><br />Thymosin Alpha-1 acts on the immune education layer, not just on acute effector cells. For someone thinking about immune architecture across decades, supporting the foundational education pathway rather than just boosting downstream effectors has a different quality to it.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The approved clinical data is in people with active viral disease and cancer — populations where immune competence is dramatically depressed. Whether supplementing thymosin alpha-1 in an aging but otherwise healthy adult produces meaningful immune calibration improvements is not established by human trials. The most advanced clinical context for thymosin alpha-1 is in severe immune suppression, not optimization of immune aging. There is also the autoimmune consideration: a compound that activates T cells and antigen-presenting cells is not inherently safe for everyone. Net: the most mechanistically grounded immune-longevity peptide with actual human data, but the longevity optimization evidence is still largely theoretical.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What Thymosin Alpha-1 is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Proven for immune resilience in healthy adults — the clinical evidence is in specific immune-compromised populations</li>
              <li>Appropriate for anyone with autoimmune disease — immune activation can significantly worsen autoimmune conditions</li>
              <li>An acute infection treatment — it modulates immune education, not acute pathogen response</li>
              <li>FDA-approved in the US — available via compounding, but no US approval exists</li>
              <li>An immune stimulant — it calibrates and matures the immune response, which is a different mechanism than stimulating it</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>Approved in approximately 35 countries — more clinical experience than most community immune peptides</li>
              <li>Human trial data in hepatitis and cancer immune contexts — the most clinically credentialed immune peptide</li>
              <li>Supports T cell maturation and dendritic cell activation — upstream immune architecture, not just downstream effectors</li>
              <li>Addresses thymic involution — directly relevant to one of the most documented features of immune aging</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
